P. Makris

发表

Title : Clinical usefulness of bone turnover marker levels in osteoporosis Corresponding

Konstantinos, P. Makris, 2016 .

Helicobacter pylori infection in upper gastrointestinal bleeding in patients with hereditary hemorrhagic disorders.

P. Makris, N. Eleftheriadis, Sofia Makri, 2002, European journal of internal medicine.

Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients.

D. Grekas, A. Sioulis, P. Malindretos, 2009, Hippokratia.

Comparative effects of synthetic pentasaccharide, low-molecular-weight heparin, unfractionated heparin and recombinant hirudin on the generation of factor VIIa and prothrombin activation after coagulation of human plasma.

M. Bloch, M. Samama, G. Gerotziafas, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly

D. Goulis, Z. Efstathiadou, D. Farmakiotis, 2008, Clinical endocrinology.

High frequency of factor V Leiden and prothrombin G20210A mutations in Greek hemophiliacs

T. Constantinidis, T. Constantinidis, A. Lambropoulos, 2003, Journal of thrombosis and haemostasis : JTH.

Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome.

G. Louridas, A. Ziakas, P. Makris, 2005, Journal of interventional cardiology.

Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant

D. Tsakiris, L. Settas, P. Makris, 1989, Thrombosis and Haemostasis.

Defective Platelet Aggregation in Myelodysplastic Syndromes

A. Papadopoulos, G. Ntaios, P. Makris, 2007, Acta Haematologica.

Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.

D. S. Houston, M. Morfini, M. Torchet, 2001, Seminars in hematology.

Bilateral central retinal artery occlusions in a patient with activated protein C resistance

H. Piperidou, P. Makris, J. Heliopoulos, 1997 .

Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant.

D. Tsakiris, L. Settas, P. Makris, 1989, Thrombosis and haemostasis.

Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole blood.

M. Bloch, M. Samama, G. Gerotziafas, 1996, Thrombosis research.

Haemarthrosis after superwarfarin poisoning

A. Boutou, G. Ntaios, P. Makris, 2007, European Journal of Haematology.

Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden

P. Makris, N. Eleftheriadis, 2010, Therapeutics and clinical risk management.

Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden nikos Eleftheriadis

P. Makris, 2010 .

TEN YEARS FOLLOW UP OF HEREDITARY HAEMORRHAGIC PARIENTS IN DENTAL PRACTICE

P. Makris, M. Makris, S. Makris, 2007 .

Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.

M. Morfini, M. Torchet, C. Berger, 2001, Seminars in hematology.

Marathon Run: Effect on Antithrombin III

P. Makris, A. Dessypris, T. Mandalaki, 1978, Thrombosis and Haemostasis.

Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.

D. Tsakiris, L. Settas, P. Makris, 1990, The Journal of rheumatology.

Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.

T. Agorastos, G. Karas, A. Lambropoulos, 2000, Human reproduction.

Pseudothrombocytopenia: A Rare Phenomenon

G. Gerotziafas, P. Makris, A. Kioumi, 1998 .

Long Lasting Sitting Position and Haemostasis

D. Tsakiris, P. Makris, T. Mandalaki, 1986, Thrombosis and Haemostasis.

Changes In TNF-Alpha Levels, Microcirculation Status, And Oxidation Products After Liver Ischemia/Reperfusion Injury In Mice

A. Michalopoulos, V. Papadopoulos, Z. Iakovidou-Kritsi, 2004 .

Peptide analogues of 1811–1818 loop of the A3 subunit of the light chain A3-C1–C2 of FVIII of blood coagulation: biological evaluation

M. Liakopoulou-Kyriakides, C. Koutsas, P. Makris, 2010, Amino Acids.

Factor V Leiden in Greek thrombophilia patients: relationship with activated protein C resistance test and levels of thrombin‐antithrombin complex and prothrombin fragment 1+2

M. Makris, M. Daly, A. Lambropoulos, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Palliative treatment of painful bone metastases from non-Hodgkin lymphoma with disodium pamidronate.

V. Kouloulias, P. Makris, I. Sofroniadis, 2002, Journal of experimental & clinical cancer research : CR.

Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case

P. Boura, K. Tselios, P. Skendros, 2005, Clinical Rheumatology.

Clinical evaluation of new global clotting assay for monitoring of LMWH treatment: pilot study.

P. Makris, E. Pithara, 1998, International Angiology.